Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market [Yahoo! Finance Canada]
![Yahoo! Finance Canada](../../../Content/images/providers/Yahoo! Finance Canada.png)
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance Canada
Lilly ( LLY ) and Novo Nordisk ( NVO ). Goldman Sachs US Lead Biotechnology Analyst Salveen Richter joins Catalysts to discuss the state of the weight-loss market and the potential headwinds for these pharmaceutical companies. "There's been a duopoly situation via Lilly and Novo," Richter explains. She points to Zealand ( ZEAL.CO ), Amgen ( AMGN ), and Regeneron ( REGN ) as companies she's watching that could become competitors in the weight-loss market. She notes that Eli Lilly and Novo Nordisk are facing limited supply as demand skyrockets. The two pharmaceutical companies have to make significant investments to expand manufacturing capabilities, and Richter explains, "I think what everybody realizes is based on the opportunity, the investment in manufacturing and supply has to come in much earlier than perhaps thought before." For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl Vi
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NVO) Gains As Market Dips: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Obesity drug from Zealand shows potential in early trial [Yahoo! Finance]Yahoo! Finance
- I've been practicing medicine at a renowned institution for 40 years. Society isn't ready for us to reverse the aging process across an entire population [Yahoo! Finance]Yahoo! Finance
- Ozempic drugmaker is 'ripping off the American people' with high prices, says Bernie Sanders [MSNBC.com]MSNBC.com
- Eli Lilly Has a New Drug That Could Push the Stock Higher [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 6/17/24 - Form 6-K
- 6/10/24 - Form 6-K
- 6/3/24 - Form 6-K
- NVO's page on the SEC website